TABLE 1.
Virus-specific analysis of healthy subjects
| Subject no. | Sex | Age (in yrs) | Tetramer-specific T cell populations detected |
|---|---|---|---|
| 1 | Male | 36 | RSV NP, influenza MP1, EBV EBNA3a (RLR), EBV BMLF-1 |
| 2 | Male | 40 | RSV NP, influenza MP1, EBV EBNA3a (RPP), EBV BMLF-1 |
| 3 | Female | 37 | Influenza MP1, EBV BMLF-1, hCMV pp65 (NLV) |
| 4 | Female | 24 | Influenza MP1, EBV BMFL-1 (HPV), EBV BMLF-1 |
| 5 | Male | 49 | RSV NP, influenza MP1, EBV EBNA3a (RPP), EBV BMLF-1, hCMV pp65 (NLV and TPR) |
| 6 | Unknown | Unknowna | hCMV pp65 (NLV) |
| 7 | Unknown | Unknowna | hCMV pp65 (NLV) |
| 8 | Unknown | Unknowna | RSV NP, EBV EBNA3a (RLR and RPP) |
| 9 | Female | 37 | RSV NP, EBV EBNA3a (RPP and FLR) |
| 10 | Male | 24 | hCMV pp65 (NLV) |
| 11 | Female | 37 | hCMV pp65 (NLV) |
In between 18 and 64 years of age.